A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Trial details
- Registry ID
- NCT07592689
- Drugs studied
- DT120
TrialRedline tracks 7 clinical trials sponsored by Definium Therapeutics US, Inc.: 4 Phase 3, 3 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 | DT120 | Recruiting | 2027-09Estimated |
| A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)NCT06809595 | DT120 | Active not recruiting | 2026-08-13Actual |
| A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 | DT120 | Active not recruiting | 2026-07-15Actual |
| A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844 | DT120 | Active not recruiting | 2026-05-20Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Phase 2A Trial of DT402 for Autism Spectrum DisorderNCT07303907 | DT402 (R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA)) | Completed | 2026-09-16Actual |
| Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept TrialNCT05200936 | MM120 | Completed | 2023-11-06Actual |
| A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064 | MM120 | Completed | 2023-10-06Actual |
Names as written in the registry records.
NCT07303907 · Definium Therapeutics US, Inc.
Before: Estimated. After: Actual.
Before: 20 participants (planned). After: 5 participants (actual).
Before: Estimated. After: Actual.
Before: Aug 2027. After: 16 Sep 2026.
Before: Recruiting. After: Completed.
NCT06809595 · Definium Therapeutics US, Inc.
Before: Estimated. After: Actual.
Before: Aug 2026. After: 13 Aug 2026.
NCT06741228 · Definium Therapeutics US, Inc.
Before: Estimated. After: Actual.
Before: Jul 2026. After: 15 Jul 2026.
NCT06809595 · Definium Therapeutics US, Inc.
Before: Nov 2026. After: Aug 2026.
NCT06941844 · Definium Therapeutics US, Inc.
Before: Estimated. After: Actual.
Before: Nov 2026. After: 20 May 2026.
NCT06741228 · Definium Therapeutics US, Inc.
Before: May 2026. After: Jul 2026.
NCT06809595 · Definium Therapeutics US, Inc.
Before: Estimated. After: Actual.
Before: 250 participants (planned). After: 245 participants (actual).
NCT06809595 · Definium Therapeutics US, Inc.
Before: Recruiting. After: Active not recruiting.
NCT06741228 · Definium Therapeutics US, Inc.
Before: Estimated. After: Actual.
Before: 200 participants (planned). After: 214 participants (actual).
Before: Recruiting. After: Active not recruiting.
NCT06941844 · Definium Therapeutics US, Inc.
Before: Estimated. After: Actual.
Before: 140 participants (planned). After: 149 participants (actual).
Before: Recruiting. After: Active not recruiting.